Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Int J Obes (Lond). 2011 Apr 5;36(2):244–253. doi: 10.1038/ijo.2011.78

Figure 8.

Figure 8

A) Representative Western blots from muscle of control and CoPP treated loxTB mice. B) Levels of HO-1 protein. C) Levels of pAMPK. D) Levels of glucose transporter 4 (Glut 4). * =P< 0.05 as compared to corresponding value in non-CoPP treated mice, n=6/group.